Abstract: Described herein is an octenyl succinic acid modified starch (OSA modified starch) degraded by at least one enzyme capable of cleaving 1,4-linkages of a starch molecule from the non-reducing ends to produce short chain saccharides, wherein the content of non-covalently bound, free octenyl succinic acid in the OSA modified starch is less than about 0.50% by weight, based on total weight of the modified starch, and wherein content of alpha-1,6-glycosidic linkages is higher than 12%, a method of preparing same, and an encapsulation agent comprising same as well as a method of encapsulating an active agent with said encapsulation agent.

Abstract: Described herein is an octenyl succinic acid modified starch (OSA modified starch) degraded by at least one enzyme capable of cleaving 1,4-linkages of a starch molecule from the non-reducing ends to produce short chain saccharides, wherein the content of non-covalently bound, free octenyl succinic acid in the OSA modified starch is less than about 0.50% by weight, based on total weight of the modified starch, and wherein content of alpha-1,6-glycosidic linkages is higher than 12%, a method of preparing same, and an encapsulation agent comprising same as well as a method of encapsulating an active agent with said encapsulation agent.

Abstract: The use of substances that are generally recognized as safe for cosmetic or pharmaceutical applications and that have positive solution enthalpy, in particular sugar alcohols of general formula (I) where N=3, 4 and 5, preferably xylitol, in cosmetic or medicinal topical preparations is characterized in that the substances or substances in the preparations are present in a largely water-free medium and/or are shielded from an aqueous medium by a material barrier.

Abstract: Compositions of(a) one or more fatty alcohols selected from the group of the branched or unbranched alkyl alcohols having 16-22 C atoms,(b) one or more wax esters,(c) optionally highly disperse silica,(d) optionally one or more cosmetic and/or pharmaceutical active substances,(e) and optionally conventional pharmaceutical or cosmetic auxiliaries and/or additives.